X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Chinese Journal of Cancer Research

期刊標題檢索 CHINESE J CANCE 最新評論: How many reviewers are there? (2024-09-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Chinese Journal of Cancer Research]您好,您是該頁面的第 41733 位訪客。

期刊簡介
期刊名稱Chinese Journal of Cancer Research Chinese Journal of Cancer Research
LetPub Score
7.0
50 ratings
Rate

Reputation
8.7

Influence
5.6

Speed
7.0

期刊簡稱CHINESE J CANCER RES
ISSN1000-9604
E-ISSN1993-0631
h-indexN.A.
CiteScoreN.A.
自引率 (2023-2024)14.30%自引率趨勢
掲載範囲
Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631; www.thecjcr.org) is published by AME Publishing Company (www.amepc.org) in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013.

CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.
官方網站https://www.springer.com/journal/11670
在線稿件提交https://mc03.manuscriptcentral.com/cjcr
開放訪問No
出版商Springer Berlin Heidelberg
主題領域医学
出版國/地區PEOPLES R CHINA
發行頻率四半期刊行
創刊年1988
每年文章數51每年文章數趨勢
黃金OA百分比94.30%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ141/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1000-9604%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 4.5 Month(s)
競爭力 *來自作者的數據: About 62.5%
參考鏈接
相關期刊 【Chinese Journal of Cancer Research】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS332120
    CANCER RESEARCH312143
    BMC CANCER245834
    Asian Pacific Journal of Cancer Prevention220291
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH198019
    INTERNATIONAL JOURNAL OF CANCER191641
    CLINICAL CANCER RESEARCH181676
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY177125
    ONCOLOGY REPORTS175040
    CA-A CANCER JOURNAL FOR CLINICIANS163658
  •  

    Chinese Journal of Cancer Research Chinese Journal of Cancer Research
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Chinese Journal of Cancer Research] 的評論撰寫評論
作者: 佐拉瓦利斯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-05 14:10:32 評論於
How many reviewers are there?
(0) 讚! | 佐拉瓦利斯

作者: 水之小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-27 12:55:28 評論於
Excuse me, how much is the layout fee?
(0) 讚! | 水之小娘子

作者: 龙爪之霜


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-20 18:50:01 評論於
Some magazines need to be edited before you can even access them without logging in to the system
(0) 讚! | 龙爪之霜

作者: 天池玉琲


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-30 12:18:19 評論於
Has the corresponding author not received the email about the submission?
(0) 讚! | 天池玉琲

作者: 英慧小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-28 12:16:01 評論於
Wow, is it a major repair or a minor repair?
(0) 讚! | 英慧小哥哥

作者: 震雷智美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-16 15:01:59 評論於
Research Focus: Tumor Experience Sharing: CJCR is still very powerful, although the impact factor needs to be improved temporarily, the speed is still excellent. Submitted on March 18, revised on April 3, after careful editing and polishing submitted on the 14th, and accepted on the 17th. Give a shoutout to CJCR
(0) 讚! | 震雷智美

作者: 太山佩玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-02 15:28:24 評論於
Please translate the following paragraph into English and Japanese, and use ":" and ":" as headings: 4.026
(0) 讚! | 太山佩玉

作者: 霸王乐珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-07 09:15:50 評論於
What is the current impact factor of CHINESE J CANCER RES? I couldn't find it
(0) 讚! | 霸王乐珍

作者: 佛光烨赫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-19 17:04:17 評論於
Review speed: 24.0 | Submission success rate: 5.0 Experience sharing: Do you not have a sense of belonging to any magazine? Chinese magazines are not well received, with a tendency to admire foreign ones! Is it meaningful to be classified as T1 by the China Association for Science and Technology?
(0) 讚! | 佛光烨赫

作者: 鹤轩小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-19 08:58:21 評論於
It says there are case studies in the description, but there is no option for that type on the submission page. Does this mean you are not accepting them anymore?
(0) 讚! | 鹤轩小公主

作者: 雨巷少年意映


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-09 23:09:23 評論於
Do you have any recent submission experience to share with CHINESE J CANCER RES?
(0) 讚! | 雨巷少年意映

作者: 中原宇荫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-28 22:17:04 評論於
Chinese magazines are not good enough, always admiring foreign things!
(0) 讚! | 中原宇荫

作者: 龙鳞凯定


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-11-21 20:40:29 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Experience sharing: Submitted on November 16, 2018, rejected on November 21, reason being not novel enough
(0) 讚! | 龙鳞凯定

作者: 璃月项明


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-08-07 23:26:42 評論於
Started submitting from December 2017, revised three times, and finally accepted in August 2018. The review process was very strict, and the reviewers examined the content in great detail. The statistician reviewer was very professional. The questions were sharp and to the point. Looking back, 10 years ago when I submitted to CJCR, it was enough to just recommend two reviewers. However, at that time the impact factor was only 0.9
(0) 讚! | 璃月项明

作者: 中原宇荫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-04-01 16:48:01 評論於
Chinese magazines. Gray-market goods
(0) 讚! | 中原宇荫

作者: 碧桃俊艾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-14 15:31:06 評論於
Review Speed: 2.0 | Submission Acceptance Rate: 50.0 Experience Sharing: Submitted on February 27, major revisions on April 16, revised on May 10, minor revisions on June 5, revised on June 6, accepted on June 9. Currently in "awaiting to batch" status
(0) 讚! | 碧桃俊艾

作者: 重阳嘉美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-20 17:55:43 評論於
Trashy magazines, awesome!
(0) 讚! | 重阳嘉美

作者: 半梦大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-10-07 18:27:59 評論於
@2000py, how is this magazine?
(0) 讚! | 半梦大叔

作者: Eve Faraday


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-09-10 22:57:42 評論於
Trashy magazines, nothing innovative, but totally awesome
(0) 讚! | Eve Faraday

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-12-10 23:29:20 評論於
Your submission was not accepted, it was rejected outright in one month without reason
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-11-04 16:35:42 評論於
The review process for domestic magazines is the same, including the Chinese Medical Journal
(0) 讚! | 凌霄高洁

作者: 桃花夜雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-08-25 14:26:05 評論於
Why does everyone say this magazine is rubbish?
(0) 讚! | 桃花夜雪

作者: 形意山桃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-01-04 17:50:53 評論於
I want to say that my article has not been replied for a long time. I called and the person who answered the phone asked another person what was going on, and the other person said it was terrible. Without changing a word, I submitted it to Medical Oncology. The impact factor that year rose to 2.21. I think the thinking and direction of this journal are not right, the articles they publish are just like those translated from Chinese journals, with too many formal requirements and cannot keep up with international standards. However, foreign journals focus on different aspects, as long as there is something new and the design is reasonable, it can be published. This suggestion is for reference only
(0) 讚! | 形意山桃

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-06-29 10:40:40 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Experience sharing: Review speed: average, not much different from other domestic journals. After minor revisions, it was directly accepted. It is a quarterly journal, and the paper will only be published half a year after acceptance. From submission, revisions, acceptance, to final publication, it took a full 10 months. Not recommended for comrades in a hurry to publish!
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-05-06 11:20:01 評論於
Procrastinating manuscript processing will eventually ruin this magazine
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Chinese Journal of Cancer Research] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*